Futurity

Asthma doesn’t seem to boost COVID-19 risk

Having asthma doesn't appear to increase the risk you'll get a severe or deadly case of COVID-19, researchers report.
A health care worker in protective masks and gown holds a patient's hand surrounded by blue curtains

Asthma does not seem to increase the risk of a person contracting COVID-19 or influence its severity, according to new research.

Researchers say further study is needed but those with the chronic respiratory disease don’t appear to be at a higher risk of getting extremely ill or dying from coronavirus.

“Older age and conditions such as heart disease, high blood pressure, chronic obstructive pulmonary disease, diabetes, and obesity are reported risk factors for the development and progression of COVID-19,” says Reynold A. Panettieri Jr., a pulmonary critical care physician and director of the Rutgers University Institute for Translational Medicine and Science and coauthor of a paper in the Journal of Allergy and Clinical Immunology.

“However, people with asthma—even those with diminished lung function who are being treated to manage asthmatic inflammation—seem to be no worse affected by SARS-CoV-2 than a nonasthmatic person. There is limited data as to why this is the case—if it is physiological or a result of the treatment to manage the inflammation.”

Here, Panettieri explains what we know about asthma and COVID-19 and the important questions that remain:

The post Asthma doesn’t seem to boost COVID-19 risk appeared first on Futurity.

More from Futurity

Futurity3 min read
How Can Physics Become More Diverse?
A new paper explores the problems with physics culture and provides a road map for making departments in the field more equitable. Physics has long suffered from the perception that the most cutting-edge work is done by lone geniuses, usually white m
Futurity1 min read
How You Can Reverse Insulin Resistance
What is insulin resistance and how can you reverse it? An expert has answers for you. Gerald I. Shulman, a professor of medicine (endocrinology) and cellular and molecular physiology, investigator emeritus of the Howard Hughes Medical Institute, and
Futurity3 min read
Team Pins Down Huge Cost Of Mental Illness In The US
A new analysis of the economic toll of mental illness considers a host of adverse economic outcomes not considered in earlier estimates. Mental illness costs the US economy $282 billion annually, which is equivalent to the average economic recession,

Related Books & Audiobooks